Zimbabwe is allowing the sale of hemp-based products as complementary medicine for patients.
“The Authority is now receiving and assessing applications for approval for HEMP-Bases Cannabidiol (CBD) products as complementary medicines,” says the regulator in a circulatory.
The country’s Medicine Control Authority of Zimbabwe is inviting licensed cannabis producers, manufacturers, importers, and retailers to seek approval to sell the products, calling for product samples for inspection.
Stakeholders will also need to seek registration to offer the hemp-based complementary medicines as well as their analyses to show the quantities of hemp extracts in their products.
As part of the applications, interested producers, manufacturers and retail pharmacists will also provide warnings and contraindications of their products, opening up their manufacturing sites for inspection by the authority.
Unlicensed sellers risk prosecution for selling unapproved medicine.
“Any hemp-based CBD product applications that do not meet the criteria above may not be approved for distribution and will be confiscated. Further, sellers may be prosecuted for selling unapproved complementary medicines.”
Zimbabwe is looking to boost its income from cannabis, shifting away from tobacco as its main crop, targeting annual revenues of $1.25 billion.
In May, President Emmerson Mnangagwa commissioned a $27 million farm and processing plant by Swiss Bioceuticals Limited.